Prograf and Failure to thrive - a phase IV clinical study of FDA data

Summary:

Failure to thrive is reported as a side effect among people who take Prograf (tacrolimus), especially for people who are male, 50-59 old, have been taking the drug for 6 - 12 months also take Cellcept, and have Osteoporosis.

The phase IV clinical study analyzes which people have Failure to thrive when taking Prograf. It is created by eHealthMe based on reports of 41,725 people who have side effects when taking Prograf from the FDA, and is updated regularly.

What is Prograf?

Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 42,230 Prograf users. Check the latest studies of Prograf.

What is Failure to thrive?

Failure to thrive (inadequate weight gain and physical growth in children) is found to be associated with 771 drugs and 1,168 conditions by eHealthMe. Check the latest studies of Failure to thrive.

On Aug, 09, 2026

41,725 people reported to have side effects when taking Prograf.
Among them, 64 people (0.15%) have Failure to thrive.

Among these 64 people:

How long have people been on Prograf when they have Failure to thrive? *

What is the gender of people who have Failure to thrive when taking Prograf? *

female: 25.81 %
male: 74.19 %

What is the age of people who have Failure to thrive when taking Prograf? *

What are other drugs people take besides Prograf? *

Cellcept: 16 people, 25.00%
Prednisone: 14 people, 21.88%
Mycophenolate Mofetil: 14 people, 21.88%
Bactrim: 11 people, 17.19%
Fosamax: 9 people, 14.06%
Synthroid: 8 people, 12.50%
Nexium: 8 people, 12.50%
Prozac: 7 people, 10.94%
Valcyte: 7 people, 10.94%
Toprol-Xl: 7 people, 10.94%

What are other side effects people have besides Failure to thrive? *

Acute Kidney Failure: 20 people, 31.25%
Anaemia (lack of blood): 18 people, 28.12%
Nausea (feeling of having an urge to vomit): 15 people, 23.44%
Diarrhea: 13 people, 20.31%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 12 people, 18.75%
Chronic Renal Failure (kidney failure): 11 people, 17.19%
High Blood Pressure: 11 people, 17.19%
Weakness: 11 people, 17.19%
Dehydration (dryness resulting from the removal of water): 10 people, 15.62%
Sepsis (a severe blood infection that can lead to organ failure and death): 10 people, 15.62%

What are the existing conditions these people have? *

Constipation: 4 people, 6.25%
Osteoporosis (bones weak and more likely to break): 4 people, 6.25%
Depression: 3 people, 4.69%
High Blood Pressure: 3 people, 4.69%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 4.69%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 3 people, 4.69%
Insomnia (sleeplessness): 3 people, 4.69%
Urination - Excessive At Night: 2 people, 3.12%
Nausea (feeling of having an urge to vomit): 2 people, 3.12%
Fever: 2 people, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Prograf and have Failure to thrive?

- Check whether Failure to thrive is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prograf:

Prograf (42,230 reports)

Browse all side effects of Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Failure to thrive:

Failure to thrive (771 drugs)

Browse all the conditions that are associated with Failure to thrive:

Failure to thrive (1,168 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Prograf) and Prograf (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.